# Ardelyx (ARDX) — Overview

ARDX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ardx

## Price

Last close $3.27 on Oct 15, 2026. 52-week range $3.12 – $7.99.

## Company profile

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $450.9M |
| Revenue (quarter) | $120.9M |
| Revenue growth (year over year) | 23.77% |
| Gross profit (trailing twelve months) | $425.5M |
| Gross margin | 94.37% |
| Net income (trailing twelve months) | −$55.7M |
| Net income (quarter) | −$16.7M |
| Net income growth (year over year) | 12.36% |
| Net margin | -12.35% |
| Return on equity | -38.61% |
| EPS (trailing twelve months) | −$0.23 |
| Book value per share | $0.60 |
| P/E (trailing twelve months) | — |
| Price to book | 5.5 |
| Debt to assets | 74.12% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Ardelyx (ARDX) profitable?

No. Ardelyx reported a net loss of $55.7M over the trailing twelve months.

### How much revenue does Ardelyx (ARDX) make?

Ardelyx generated $450.9M in revenue over the trailing twelve months, up 23.77% year over year.

### How do I buy stock in Ardelyx (ARDX)?

ARDX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).